Your browser doesn't support javascript.
loading
Gut Inflammation Markers, Diet, and Risk of Islet Autoimmunity in Finnish Children - A Nested Case-Control Study.
Salo, Tuuli Ei; Hakola, Leena; Niinistö, Sari; Takkinen, Hanna-Mari; Ahonen, Suvi; Puustinen, Leena; Ilonen, Jorma; Toppari, Jorma; Veijola, Riitta; Hyöty, Heikki; Knip, Mikael; Virtanen, Suvi M.
Affiliation
  • Salo TE; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland. Electronic address: tuuli.salo@thl.fi.
  • Hakola L; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland; Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
  • Niinistö S; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Takkinen HM; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland; Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
  • Ahonen S; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland; Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
  • Puustinen L; Department of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Ilonen J; Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
  • Toppari J; Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, and Centre for Population Health Research, University of Turku, Turku, Finland; Department of Pediatrics, Turku University Hospital, Turku, Finland.
  • Veijola R; Department of Pediatrics, PEDEGO Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland; Department of Children and Adolescents, Oulu University Hospital, Oulu, Finland.
  • Hyöty H; Department of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland; Fimlab laboratories, Tampere, Finland.
  • Knip M; Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland; Department of Pediatrics, Tampere University Hospital, T
  • Virtanen SM; Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; Unit of Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland; Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland; Center for Child Hea
J Nutr ; 154(7): 2244-2254, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38795745
ABSTRACT

BACKGROUND:

Gut dysbiosis and increased intestinal permeability have been reported to precede type 1 diabetes-related autoimmunity. The role of gut inflammation in autoimmunity is not understood.

OBJECTIVES:

This study aimed to assess whether gut inflammation markers are associated with risk of islet autoimmunity and whether diet is associated with gut inflammation markers.

METHODS:

A nested case-control sample of 75 case children with islet autoimmunity and 88 control children was acquired from the Finnish Type 1 Diabetes Prediction and Prevention cohort. Diet was assessed with 3-d food records, and calprotectin and human ß-defensin-2 (HBD-2) were analyzed from stool samples at 6 and 12 mo of age. Conditional logistic regression analysis was used in a matched case-control setting to assess risk of autoimmunity. Analysis of variance, independent samples t test, and a general linear model were used in secondary analyses to test associations of background characteristics and dietary factors with inflammation markers.

RESULTS:

In unadjusted analyses, calprotectin was not associated with risk of islet autoimmunity, whereas HBD-2 in the middle (odds ratio [OR] 3.23; 95% confidence interval [CI] 1.03, 10.08) or highest tertile (OR 3.02; 95% CI 1.05, 8.69) in comparison to the lowest at 12 mo of age showed borderline association (P-trend = 0.063) with higher risk of islet autoimmunity. Excluding children with cow milk allergy in sensitivity analyses strengthened the association of HBD-2 with islet autoimmunity, whereas adjusting for dietary factors and maternal education weakened it. At age 12 mo, higher fat intake was associated with higher HBD-2 (ß 0.219; 95% CI 0.110, 0.328) and higher intake of dietary fiber (ß -0.294; 95% CI -0.510, -0.078), magnesium (ß -0.036; 95% CI -0.059, -0.014), and potassium (ß -0.003; 95% CI -0.005, -0.001) with lower HBD-2.

CONCLUSIONS:

Higher HBD-2 in infancy may be associated with higher risk of islet autoimmunity. Dietary factors play a role in gut inflammatory status.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Autoimmunity / Islets of Langerhans / Beta-Defensins / Leukocyte L1 Antigen Complex / Diabetes Mellitus, Type 1 / Diet Limits: Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: J Nutr Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Autoimmunity / Islets of Langerhans / Beta-Defensins / Leukocyte L1 Antigen Complex / Diabetes Mellitus, Type 1 / Diet Limits: Female / Humans / Infant / Male Country/Region as subject: Europa Language: En Journal: J Nutr Year: 2024 Document type: Article